May 20, 2020
19:10
For every 10 shares held, investors received 19. The price per share adjusted from $121.60 to $64.00.
The split itself did not change the total investment value.
Jafron Biomedical Co., Ltd. Class A (SZSE:300529) operates in the Medical specialties industry.
Jafron Biomedical Co., Ltd. Class A company overviewJafron Biomedical Co., Ltd. Class A's most recent stock split was on May 20, 2020. It was a 19-for-10 forward split, so shareholders received 19 shares for every 10 they held.
Jafron Biomedical Co., Ltd. Class A has split its stock once. This history records one forward split, on May 20, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Jafron Biomedical Co., Ltd. Class A's 19-for-10 split on May 20, 2020, every 10 shares became 19 shares.
Jafron Biomedical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 20, 2020, 6 years ago. Companies announce splits in advance, and any new SZSE:300529 split will appear on this page.
Already premium?